Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on May 28, 2026 by admin

The Efficacy of Psilocybin Therapy for Depression in Parkinson’s Disease

Conditions: Depression; Parkinson’s Disease (PD)

Interventions: Drug: Psilocybin (drug); Drug: Psilocybin (drug)

Sponsors: Yale University; Michael J. Fox Foundation for Parkinson’s Research

Not yet recruiting
CategoriesClinicalTrials.gov TagsAcademic research, Alternative therapies, Depression, Mood and emotional regulation, News Approved, Sexual drive and regulation

Post navigation

Previous PostPrevious Stress Management and Meditative Movements for Asian Americans With Depression and Physical Symptoms
Next PostNext EEG Prediction and Clinical Efficacy of tDCS in Major Depression
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.